Back

Exacerbated muscle sympathetic nerve activity and blunted vagal reactivation in patients with heart failure and sarcopenia

26 August 2017 (12:35 - 13:25)
Organised by:
Congress Presentation Part of: Fat and skeletal muscles in heart failure Peripheral circulation, metabolism and skeletal muscle ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Guilherme Fonseca

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Skeletal muscle of the lower limb, and not the trunk, is the site that is associated with myocardial diastolic function
Mr B. Keng (Singapore, SG)
Abstract Slides
Presentation thumbnail
Characteristics and prognostic impact of muscle wasting and fat mass in heart failure with preserved ejection fraction
Doctor M. Konishi (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Serum metabolomic profiling of patients with heart failure with reduced ejection fraction reveals differences between ischemic and dilated cardiomyopathy
Doctor R. Pistulli (Munster, DE)
Abstract
Presentation thumbnail
Assessment of the relationship between novel proteins and cardiac cachexia in heart failure patients with reduced ejection fraction: adropin and irisin
Associate Professor A. Celik (Mersin, TR)
Abstract Slides
Presentation thumbnail
The lipid paradox in patients hospitalized for acute heart failure
Doctor C. Liu (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Fat and skeletal muscles in heart failure

The Event

Event poster

ESC Congress 2017

26 August 2017 12:35 CET
You may be interested in
thumbnail
Congress Presentation
Skeletal muscle and heart.
21 May 2022
thumbnail
Congress Presentation
Sympathetic nerve activation in heart failure and iron deficiency
29 June 2021
thumbnail
Congress Presentation
Comparison of prognostic values of muscle mass assessed by dual-energy X-ray absorptiometry and bioelectrical impedance analysis in old hospitalized patients with heart failure
29 June 2021
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources